NorthWest Biotherapeutics Inc (NWBO)

[Know-Fear]

No doubt. You and Poor Man have been noodling this and I have no real meat to add. Except the trial will perhaps be interesting/enlightening from a couple of possible prospectives. One being AE’s (adverse effects) could indicate the effectiveness of the combo and not necessarily be a “bad thing” for this trial. And two, being the possibility of the combo increasing the effectiveness of L to the overall spectrum of glioblastoma subtypes.